These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30656000)

  • 21. Correlation between serum prolactin levels and lupus activity.
    Rezaieyazdi Z; Hesamifard A
    Rheumatol Int; 2006 Sep; 26(11):1036-9. PubMed ID: 16625339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease.
    Allen SH; Sharp GC; Wang G; Conley C; Takeda Y; Conroy SE; Walker SE
    Lupus; 1996 Feb; 5(1):30-7. PubMed ID: 8646222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
    Leaños A; Pascoe D; Fraga A; Blanco-Favela F
    Lupus; 1998; 7(6):398-403. PubMed ID: 9736323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.
    Paraiba DB; Soares CR; Bartolini P; Arthuso FS; Borba EF; Bonfa E; Bronstein MD
    Clin Exp Rheumatol; 2010; 28(6):866-72. PubMed ID: 21205462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone.
    McMurray R; Keisler D; Izui S; Walker SE
    Clin Immunol Immunopathol; 1994 Jun; 71(3):338-43. PubMed ID: 8200135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia].
    Leaños Miranda L; Bustos López HH; Fraga Mouret A; Blanco Favela F; Dalila Pascoe Lira ME; Dalila Pascoe Lira C
    Ginecol Obstet Mex; 1998 May; 66():179-86. PubMed ID: 9646575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin in systemic lupus erythematosus.
    Pauzner R; Urowitz MB; Gladman DD; Gough JM
    J Rheumatol; 1994 Nov; 21(11):2064-7. PubMed ID: 7869311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of chronic rhinosinusitis with Sjogren's syndrome, systemic lupus erythematosus, and ankylosing spondylitis.
    Lee IH; Kim DK
    Rhinology; 2023 Apr; 61(2):124-131. PubMed ID: 36480330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity.
    Jara LJ; Gomez-Sanchez C; Silveira LH; Martinez-Osuna P; Vasey FB; Espinoza LR
    Am J Med Sci; 1992 Apr; 303(4):222-6. PubMed ID: 1562038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of serum prolactin levels in patients with systemic lupus erythematosus.
    Eglys Gómez-Hernández A; José García-Mac Gregor E; Alfonso García-Montiel D
    Invest Clin; 2016 Sep; 57(3):237-45. PubMed ID: 29938476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Buskila D; Lorber M; Neumann L; Flusser D; Shoenfeld Y
    J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NZB/W F1 mouse model for Sjögren's syndrome: A historical perspective and lessons learned.
    Bagavant H; Michrowska A; Deshmukh US
    Autoimmun Rev; 2020 Dec; 19(12):102686. PubMed ID: 33131691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients.
    Ugarte-Gil MF; Gamboa-Cárdenas RV; Zevallos F; Medina M; Cucho-Venegas JM; Perich-Campos RA; Alfaro-Lozano JL; Rodriguez-Bellido Z; Alarcón GS; Pastor-Asurza CA
    Lupus; 2014 Sep; 23(10):969-74. PubMed ID: 24718588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperprolactinemia and autoimmunity].
    Compañ González DA; Martínez Aguilar NE; Vargas Camaño ME; Guido Bayardo R
    Rev Alerg Mex; 1996; 43(5):128-32. PubMed ID: 9005005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases.
    Alani H; Henty JR; Thompson NL; Jury E; Ciurtin C
    Scand J Rheumatol; 2018 Mar; 47(2):141-154. PubMed ID: 28927315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperprolactinemia during cocaine withdrawal.
    Mendelson J; Teoh S; Lange U; Mello N; Weiss R; Skupny A
    NIDA Res Monogr; 1988; 81():67-73. PubMed ID: 3136392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin and autoimmunity.
    De Bellis A; Bizzarro A; Pivonello R; Lombardi G; Bellastella A
    Pituitary; 2005; 8(1):25-30. PubMed ID: 16411065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into the taxonomy of autoimmune diseases based on polyautoimmunity.
    Rojas M; Ramírez-Santana C; Acosta-Ampudia Y; Monsalve DM; Rodriguez-Jimenez M; Zapata E; Naranjo-Pulido A; Suárez-Avellaneda A; Ríos-Serna LJ; Prieto C; Zambrano-Romero W; Valero MA; Rodríguez Y; Mantilla RD; Zhu C; Li QZ; Toro-Gutiérrez CE; Tobón GJ; Anaya JM
    J Autoimmun; 2022 Jan; 126():102780. PubMed ID: 34923432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.